DNMT3A and myeloid neoplasm: The mechanisms of leukemogenesis by DNMT3A are not entirely clear; however, studies have shown that heterozygous Dnmt3a ablation in mice leads to an expansion of the HSC pool (38), myeloid skewing and a predisposition to myeloid malignancies that may require additional genetic alterations.